201 related articles for article (PubMed ID: 7181485)
21. [Combined in vitro effect of new betalactam antibiotics and aminoglycosides against Pseudomonas aeruginosa ].
Thabaut A; Durosoir JL; Meyran M
Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):549-54. PubMed ID: 6812006
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity of 523 blood culture isolates to 33 antibiotics.
Ode B; Forsgren A; Walder M
Scand J Infect Dis; 1984; 16(1):61-71. PubMed ID: 6559413
[TBL] [Abstract][Full Text] [Related]
23. Comparison of effectiveness of aminoglycosides and cephalosporins in gram-negative rods.
Vrbová E; Uxová M; Výmola F
Czech Med; 1986; 9(3):148-52. PubMed ID: 3095073
[TBL] [Abstract][Full Text] [Related]
24. Synergy between cephalosporin and aminoglycoside antibiotics against Providencia and Proteus.
Hyams PJ; Simberkoff MS; Rahal JJ
Antimicrob Agents Chemother; 1974 Jun; 5(6):571-7. PubMed ID: 15825407
[TBL] [Abstract][Full Text] [Related]
25. The activity of ceftazidime, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa.
Rolston KV; Chandrasekar PH; LeFrock JL; Schell RF
Chemotherapy; 1984; 30(1):31-4. PubMed ID: 6420119
[TBL] [Abstract][Full Text] [Related]
26. Latamoxef in combination with aminoglycosides against Pseudomonas aeruginosa: similarity with ticarcillin.
Sears SD; Tatem BA; Standiford HC
Chemotherapy; 1985; 31(2):102-11. PubMed ID: 3921317
[TBL] [Abstract][Full Text] [Related]
27. Synergism and antagonism of ceftizoxime and other new cephalosporins.
Moellering RC; Willey S; Eliopoulos GM
J Antimicrob Chemother; 1982 Nov; 10 Suppl C():69-79. PubMed ID: 6296032
[No Abstract] [Full Text] [Related]
28. Enhancement of the effects of anti-staphylococcal antibiotics by aminoglycosides.
Watanakunakorm C; Glotzbecker C
Antimicrob Agents Chemother; 1974 Dec; 6(6):802-6. PubMed ID: 4451352
[TBL] [Abstract][Full Text] [Related]
29. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of netilmicin and cefotaxime compared to that of other aminoglycosides.
Shah PM; Belve V
Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):285-8. PubMed ID: 552591
[TBL] [Abstract][Full Text] [Related]
31. Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model.
den Hollander JG; Horrevorts AM; van Goor ML; Verbrugh HA; Mouton JW
Antimicrob Agents Chemother; 1997 Jan; 41(1):95-100. PubMed ID: 8980762
[TBL] [Abstract][Full Text] [Related]
32. [Bactericidal activity of beta-lactams and aminoglucosides: comparative evaluations].
Dos Santos C; Monzillo V; Marone P; Concia E; Grossi P; Dughetti S
Boll Ist Sieroter Milan; 1986; 65(5):374-9. PubMed ID: 3103652
[TBL] [Abstract][Full Text] [Related]
33. [Antibiotic activity and synergism of ceftazidime and netilmicin against gram-negative pathogenic bacteria].
Baumgärtner M; Müller HP; Wundt W
Arzneimittelforschung; 1983; 33(12):1615-9. PubMed ID: 6320836
[TBL] [Abstract][Full Text] [Related]
34. Synergism at clinically attainable concentrations of aminoglycoside and beta-lactam antibiotics.
Hooton TM; Blair AD; Turck M; Counts GW
Antimicrob Agents Chemother; 1984 Oct; 26(4):535-8. PubMed ID: 6517544
[TBL] [Abstract][Full Text] [Related]
35. Comparative efficacy of fluoroquinolones, aminoglycosides, ureidopenicillins & newer cephalosporins against Pseudomonas species.
Paul K; De PK; Bhattacharya S
Indian J Med Res; 1992 May; 95():136-8. PubMed ID: 1506063
[TBL] [Abstract][Full Text] [Related]
36. In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa.
Giamarellou H; Zissis NP; Tagari G; Bouzos J
Antimicrob Agents Chemother; 1984 Apr; 25(4):534-6. PubMed ID: 6428310
[TBL] [Abstract][Full Text] [Related]
37. The Antibacterial activity in vitro and beta-lactamase stability of the new cephalosporin HR 810 in comparison with five other cephalosporins and two aminoglycosides.
Seibert G; Limbert M; Winkler I; Dick T
Infection; 1983; 11(5):275-9. PubMed ID: 6315595
[TBL] [Abstract][Full Text] [Related]
38. The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
Acred P; Ryan DM; Sowa MA; Watts CM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():247-55. PubMed ID: 19802994
[TBL] [Abstract][Full Text] [Related]
39. In-vitro antibacterial activity of cefotetan.
Grassi GG; Alesina R; Ferrara A; Peona V
J Antimicrob Chemother; 1983 Jan; 11 Suppl():45-58. PubMed ID: 6573325
[TBL] [Abstract][Full Text] [Related]
40. In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
Jorgensen JH; Crawford SA; Alexander GA
Antimicrob Agents Chemother; 1980 Jun; 17(6):937-42. PubMed ID: 6250470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
